Verenium Corporation has entered into a joint research collaboration with Syngenta AG of Switzerland. Under the agreement, Verenium gained additional exclusive rights to an array of proprietary biomolecules expressed... [read full story]
|
RELATED
|
|
Verenium Corporation (Nasdaq: VRNM ), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has entered into an agreement with Value Prior to Pulping...
Verenium Corporation, a cellulosic ethanol developer and high-performance specialty enzyme company, announced the successful closure of previously defined programs under its joint research collaboration with Syngenta...
CAMBRIDGE, Mass., Nov 03, 2009 /PRNewswire-FirstCall via COMTEX/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced...
Verenium Corporation , a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that James Levine, Executive Vice President and Chief Financial Officer, will...
Verenium Corporation , a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced the successful closure of previously defined programs under its joint research...
CAMBRIDGE, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced the successful...
CAMBRIDGE, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that James...
Verenium Corporation , a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that it will release third quarter 2009 financial results on Monday, November 9,...
